Cancer Therapeutics
Biopharmaceutical company's therapeutics candidates highlighted at conference
Published in Cancer Weekly, October 19th, 2004
Immunomedics, Inc., (IMMU) reported that its therapeutic product candidates, as well as those of its subsidiary company, IBC Pharmaceuticals, Inc., were the subject of five presentations made at the "Molecular Targets and Cancer Therapeutics" International Conference sponsored by the European Organization for Research and Treatment of Cancer (EORTC), the American Association for Cancer Research (AACR), and the National Cancer Institute (NCI).
Three of the poster presentations involved the humanized anti-CD74 monoclonal antibody conjugated with the anticancer drug, doxorubicin (DOX). The first one evaluated the in vitro efficacy of the drug conjugate on CD74-expressing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-10-19)
More Articles from Cancer Weekly
- Brain Cancer
Cannabinoids have several means for controlling glioma growth - Cancer Vaccine
Antitumor responses promoted by bone marrow from immunized donors - Head and Neck Cancer
Nitric oxide accelerates regression in head and neck cancer - Prostate Cancer
Gene expression in androgen independent disease characterized - Wilms Tumor
Shorter course of chemotherapy beneficial for children with Wilms tumor - Adenovirus Vaccine
Simian virus-tainted adenovirus vaccine does not increase cancer risk - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
